Skip Navigation


British Medical Bulletin Advance Access originally published online on April 17, 2009
British Medical Bulletin 2009 90(1):133-146; doi:10.1093/bmb/ldp012
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/1/133    most recent
ldp012v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in BMB
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lowndes, S.
Right arrow Articles by Maffulli, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowndes, S.
Right arrow Articles by Maffulli, N.
Related Collections
Right arrow Sports Medicine
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Management of unstable slipped upper femoral epiphysis: a meta-analysis

Stefanie Lowndes{dagger}, Anil Khanna{dagger}, David Emery{dagger}, Julius Sim{ddagger} and Nicola Maffulli§,*

{dagger} Trauma and Orthopaedic Surgery, University Hospital of North Staffordshire, Stoke on Trent, UK
{ddagger} School of Health and Rehabilitation, Keele University, Stoke on Trent, UK
§ Barts and The London School of Medicine and Dentistry, London, UK

* Correspondence to: Nicola Maffulli, Centre for Sports and Exercise Medicine, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Mile End Hospital, 275 Bancroft Road, London E1 4DG, UK. E-mail: n.maffulli{at}qmul.ac.uk

Introduction: The management of unstable slipped upper femoral epiphysis (SUFE) is controversial, with a high risk of developing avascular necrosis (AVN). We meta-analysed two areas of concern: reduction of the slip and the timing of treatment.

Methods: A search of Medline, CINAHL and Embase identified only retrospectively relevant studies: four regarding the role of reduction and five regarding the timing of treatment. The incidence of AVN was compared between reduced and unreduced SUFEs, and between those treated within 24 h of symptom onset and those treated thereafter.

Areas of agreement: Analysis of the pooled data gave an odds ratio of 2.20 (P = 0.290) in favour of the unreduced group, who had a lower risk of developing AVN. The odds ratio was 0.50 in favour of the group treated within 24 h from symptom onset (P = 0.441). However, though clinically important, these effects were not statistically significant.

Areas of controversy: The timing of treatment is somewhat inconsistent: two studies favour management more than 24 h after the onset of symptoms, while for three unstable SUFEs are best managed within 24 h.

Growing points: Despite the non-significant results from the meta-analysis, it can be suggested that, if reduction is to be performed, it should be undertaken cautiously, as it may be associated with increased AVN. The ideal time for management of unstable slip is probably within 24 h of symptom onset.

Areas timely for developing research: There is a strong need for multicentre, randomized, controlled trials in this area.

Keywords: slipped upper femoral epiphysis • reduction • avascular necrosis • meta-analysis

Accepted for publication March 26, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in BMB:

Editor's Choice
Norman Vetter
BMB 2009 90: 1-5. [Extract] [Full Text]  





Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.